
Please try another search
SCYNEXIS, Inc., a biotechnology company, develops medicines to overcome and prevent difficult-to-treat and drug-resistant infections in the United States. It offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis (VVC) and recurrent VVC. The company’s lead product candidate is Ibrexafungerp, a drug for the treatment of invasive candidiasis and/or candidemia, refractory invasive fungal infections, invasive aspergillosis, VVC, and recurrent VVC. It also develops SCY-247 to treat systemic fungal diseases. The company has licensing and collaboration agreements with GlaxoSmithKline Intellectual Property (No. 3) Limited, Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, CJSC (R-Pharm), and Cypralis Limited for the development, manufacture, and commercialization of ibrexafungerp. SCYNEXIS, Inc. was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. The company was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
Name | Age | Since | Title |
---|---|---|---|
Guy MacDonald | 62 | 2014 | Independent Chairman of the Board |
Steven C. Gilman | 70 | 2015 | Independent Director |
Philippe Tinmouth | 59 | 2019 | Independent Director |
Oliver Cornely | - | - | Member of Scientific Advisory Board |
Ann F. Hanham | 70 | 2008 | Independent Director |
Mahmoud Ghannoum | - | - | Member of Scientific Advisory Board |
David C. Hastings | 62 | 2015 | Independent Director |
Jack D. Sobel | - | - | Member of Scientific Advisory Board |
David W. Denning | - | - | Member of Scientific Advisory Board |
Luis Ostrosky-Zeichner | - | - | Member of Scientific Advisory Board |
Armando Anido | 65 | 2019 | Independent Director |
Barbara D. Alexander | - | - | Member of Scientific Advisory Board |
Paul Nyirjesy | - | - | Member of Scientific Advisory Board |
Peter G. Pappas | - | - | Member of Scientific Advisory Board |
David Gonzalez Angulo | 58 | 2015 | CEO, President & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review